A new review has found that a combination of endocrine inhibitors and hormone therapy is more effective in prolonging progression-free survival for advanced breast cancer patients, as compared to chemotherapy.
Northwestern Medicine scientists have created a small molecule that reduces expression of MYC, a cancer-causing protein involved in a wide variety of cancers.
The overexpression of mitochondrial superoxide dismutase, commonly found in late-stage tumors, may drive cancer stem cell formation and contribute to the failure of chemotherapy treatment in breast cancer patients.
Scientists co-led by Sui Huang, MD, PhD, found an experimental drug called metarrestin significantly reduced metastasis and cancer progression in mouse models.
Northwestern and Cell Press hosted a symposium on transcriptional regulation, welcoming more than 350 attendees from around the world.
High levels of folate, a B vitamin, can force glial nerve cells to transform back into undifferentiated stem cells, according to a new study published in the journal Stem Cells.
A revolutionary new approach that analyzes a tiny sample of blood, can detect life-threatening vascular complications in diabetic patients earlier and more accurately than traditional tests.
The first prostate cancer treatment based on the genetic makeup of the cancer resulted in significant improvements, according to a large international trial led by Northwestern Medicine investigators.
Students, faculty and staff gathered to celebrate the Driskill Graduate Program in Life Sciences, welcoming new students and recognizing distinguished upperclassmen and graduates.
The safety of a new therapy for an aggressive brain tumor was demonstrated in a recent clinical trial, and the drug also cleared other important hurdles.